Nasdaq Achv News Today

Jonestrading assumed coverage on shares of Achieve Life Sciences (NASDAQ:ACHV – Free Report) in a research report report published on Wednesday morning, Benzinga reports. The firm issued a buy rating and a $20.00 price objective on the biopharmaceutical company’s stock. Several other analysts have also issued reports on ACHV. Lake Street Capital cut their target […]

Jonestrading initiated coverage on shares of Achieve Life Sciences (NASDAQ:ACHV – Free Report) in a research note released on Wednesday, Benzinga reports. The brokerage issued a buy rating and a $20.00 price target on the biopharmaceutical company’s stock. A number of other equities research analysts have also weighed in on the company. Oppenheimer restated an […]

BerganKDV Wealth Management LLC purchased a new stake in shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV – Free Report) during the 2nd quarter, Holdings Channel reports. The fund purchased 5,000 shares of the biopharmaceutical company’s stock, valued at approximately $26,000. Other large investors have also made changes to their positions in the company. Tower Research […]

Perkins Capital Management Inc. lessened its stake in Achieve Life Sciences, Inc. (NASDAQ:ACHV – Free Report) by 37.1% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 137,212 shares of the biopharmaceutical company’s stock after selling 80,888 shares during the quarter. […]

Achieve Life Sciences (NASDAQ:ACHV – Get Rating) had its price objective lowered by Lake Street Capital from $22.00 to $19.00 in a research note issued to investors on Wednesday morning, The Fly reports. Other equities research analysts also recently issued research reports about the stock. Maxim Group increased their target price on shares of Achieve […]

Achieve Life Sciences (NASDAQ:ACHV – Get Rating) had its target price reduced by Lake Street Capital from $22.00 to $19.00 in a report issued on Wednesday morning, The Fly reports. Several other research analysts have also recently weighed in on the stock. Oppenheimer reiterated an outperform rating and set a $17.00 price target on shares […]

Achieve Life Sciences, Inc. (NASDAQ:ACHV – Get Rating) CEO John Bencich purchased 5,000 shares of the business’s stock in a transaction on Tuesday, May 30th. The stock was acquired at an average price of $5.50 per share, with a total value of $27,500.00. Following the purchase, the chief executive officer now directly owns 66,730 shares […]

Achieve Life Sciences, Inc. (NASDAQ:ACHV – Get Rating) CEO John Bencich purchased 5,000 shares of the stock in a transaction that occurred on Tuesday, May 30th. The stock was bought at an average cost of $5.50 per share, with a total value of $27,500.00. Following the acquisition, the chief executive officer now owns 66,730 shares […]

Achieve Life Sciences, Inc. (NASDAQ:ACHV – Get Rating) was the target of a significant growth in short interest in the month of May. As of May 15th, there was short interest totalling 633,200 shares, a growth of 11.2% from the April 30th total of 569,600 shares. Based on an average daily trading volume, of 156,300 […]

Achieve Life Sciences, Inc. (NASDAQ:ACHV – Get Rating) – Stock analysts at Zacks Small Cap issued their Q2 2023 earnings per share estimates for shares of Achieve Life Sciences in a research note issued on Wednesday, May 10th. Zacks Small Cap analyst J. Vandermosten forecasts that the biopharmaceutical company will earn ($0.40) per share for […]